10.1186/s12967-025-06527-x 195 HuJ.JiaoW.TangZ.WangC.LiQ.WeiM.et al
To view a copy of this licence, visit About this article Cite this article Ognard, J., Alipour Khabir, S., Ghozy, S
Medications known as GLP-1 agonists, including exenatide, liraglutide, and semaglutide, activate the GLP1R, effectively lowering blood sugar levels and facilitating weight loss in individuals with type 2 diabetes
Patient Reported Outcomes Patients rated the degree of distress associated with their belly appearance on a 9-point rating scale that was then transformed to a score from 0 (extremely upsetting and distressing) to 100 (extremely encouraging)
Recently, theyve been FDA-approved for chronic weight management due to their unique effects on the body
Frequently Bought Together Frequently Asked Questions What is Ipamorelin